M yocardial K
ϩ channels control resting membrane potentials, the amplitudes and the duration of action potentials, refractoriness, and automaticity. These channels are also targets for the actions of neurotransmitters, neurohormones, intracellular mediators, and exogenous drugs that modulate cardiac function. In addition, the properties and/or expression of these K ϩ channels are altered with myocardial disease, [1] [2] [3] [4] [5] [6] changes that affect the propagation of electrical activity and increase the propensity to develop and sustain arrhythmias. Most cardiac cells express multiple voltagegated transient outward (I to ) and delayed rectifier (I K ) K ϩ channels, as well as inward rectifier (I K1 ) and ligand-gated (I KATP and I Kach ) K ϩ channels ( Figure 1 ). Electrophysiological studies suggest that these currents are differentially distributed, 6 -8 contributing to regional differences in action potential waveforms, transmitter-mediated responses, and the impact of myocardial damage and/or disease.
A large number of K ϩ channel pore forming (␣) ( Tables 1 and  2 ) and accessory (␤) ( Table 3) subunit genes have now been identified. 8, 9 All K ϩ channel ␣ subunits are transmembrane proteins ( Figure 2A ) that assemble as tetramers or dimers ( Figure 2B ) to form K ϩ selective pores. Importantly, the presence of multiple ␣ (Tables 1 and 2 ) and ␤ (Table 3) subunit genes in each subfamily, alternative splicing of transcripts, 9 and coassembly with accessory subunits ( Figure 2C ) suggests great potential for generating K ϩ channel diversity. To probe the relationships between K ϩ channel subunit genes and functional cardiac K ϩ channels, in vitro and in vivo experimental approaches have been developed and exploited, and considerable progress has been made recently in defining the molecular correlates of a number of cardiac K ϩ channels. 10 -29 To manipulate cardiac K ϩ channel expression in vivo, either the ␣-myosin heavy chain (␣-MHC) promoter has been used to direct the cardiac specific expression 30, 31 of mutant K ϩ channel ␣ subunits in transgenic mice, 13, 15, 22, 24, 26, [32] [33] [34] [35] [36] or homologous recombination has been used to disrupt the expression of individual K ϩ channel subunit genes. 14 -18,20,26 -28,37-44 The in vivo molecular genetic manipulation of cardiac K ϩ channel expression holds promise for studies focused on exploring the functional roles of specific K ϩ channels because the lack of selective tools to discriminate individual K ϩ channel subunits has impeded detailed analysis of K ϩ channel functioning in situ. The development of in vivo genetic models should also allow direct testing of the predictions of computer models of cardiac action potentials. It is important to note, however, that the waveforms of action potentials in murine myocytes are distinct from those in larger animals, including humans (Figure 1 ), suggesting species-specific differences in the expression and/or the functional roles of individual K ϩ (and other) currents. There are also marked differences in ECG waveforms and in resting heart rates in mice compared with humans ( Figure 3 ), differences that need to be considered when evaluating the utility of the mouse as a model system. This review summarizes the progress made in defining the subunits contributing to the formation of the various types of myocardial K ϩ channels, discusses the phenotypic consequences of manipulating K ϩ channel expression in the mouse myocardium in situ, and explores the advantages, disadvantages, and limitations of the various mouse models developed. Finally, the questions that remain, the likely future areas of research, and the technical advances that will be necessary are discussed.
Molecular Dissection of Cardiac Transient
Outward K ؉ Currents, I to,f and I to,s
Voltage-gated K ϩ channels open in response to membrane depolarization and contribute to determining the amplitudes and the durations of cardiac action potentials. In most cells, transient outward (I to ) and delayed rectifier (I K ) K ϩ currents ( Figure 1 ) have been distinguished. These are broad classifications, however, and at least two transient K ϩ currents, I to,f and I to,s , and multiple components of delayed rectification, including I Kr , I Ks , and I Kur , have been described and shown to be differentially expressed. 8 These observations suggest that distinct molecular entities underlie the various K ϩ currents distinguished electrophysiologically, and considerable evidence has now accumulated to support this hypothesis. 8 In ventricular myocytes from transgenic mice expressing a pore mutant of Kv4.2 (Kv4.2W362F) that functions as a dominant negative, for example, I to,f is selectively eliminated 13 (Table 4 ). Subsequent studies revealed that I to,f is eliminated in all left and right ventricular, as well as atrial, Kv4.2W362F-expressing cells. 18, 19, 22 Action potentials and QT intervals are prolonged in Kv4.2W362F animals (Table  4) , 13, 19 demonstrating a prominent role for I to,f in ventricular repolarization in the mouse. In contrast, I to,f density is reduced (but not eliminated) in a subset of ventricular myocytes isolated from young (2-to 3-week-old) animals expressing a truncated Kv4.2 ␣ subunit, Kv4.2N, that also functions as a dominant negative 33 (Table 4) . As the Kv4.2N transgenics age, hypertrophy, chamber dilation, and interstitial fibrosis are evident and, at 10 to 12 weeks, these animals develop congestive heart failure, and the incidence of sudden death is increased. 33 Recordings from myocytes isolated from older Kv4.2N animals revealed marked reductions in I K1 , as well as I to,f , densities. 33 Although the pathological effects of Kv4.2N expression were attributed to attenuation of I to,f , 33 this interpretation is inconsistent with the results obtained in the Kv4.2W362F transgenics, which lack I to,f and are phenotypically normal. 13, 19, 24 In addition, I to,f is selectively eliminated in ventricular myocytes isolated from mice with a targeted deletion of Kv4.2 (Kv4.2 Ϫ/Ϫ ) ( Table 4) . 20 The Kv4.2 Ϫ/Ϫ mice are indistinguishable from Kv4.2W362F transgenics (Table  4) , and there is no evidence of pathology in these animals. 20 Although it was initially reported that deletion of the Kv1.4 ␣ subunit (Kv1.4
Ϫ/Ϫ ) has no detectable effects on outward K ϩ currents or action potential waveforms in mouse ventricular (Table 4) . A role for Kv1.4 in the generation of rabbit atrial I to has also been proposed, 21 and Kv1.4 has been suggested to underlie I to,s in ferret left ventricular endocardial myocytes. 45 In myocytes from Kv4.2W362F transgenics, a novel rapidly activating, slowly inactivating current, similar to I to,s in wild-type septum cells, 22 is upregulated. 13 Interestingly, when Kv4.2W362F was expressed in the Kv1.4 Ϫ/Ϫ background, both I to,f and I to,s were eliminated, revealing that Kv1.4 (I to,s ) is indeed upregulated in the ventricles of Kv4.2W362F trnsgenics. 19 Consistent with the absence of I to,f and I to,s , action potentials and QT intervals are prolonged markedly in Kv4.2W362F/Kv1.4 Ϫ/Ϫ animals ( Table 4) . 19 In addition, ventricular arrhythmias were seen in Kv4.2W362F/Kv1.4 Ϫ/Ϫ mice, 19 suggesting that upregulation of Kv1.4 (I to,s ) in Kv4.2W362F transgenics protects the heart from the arrhythmogenic effects of the loss of I to,f . Atrioventricular (AV) block is also seen in Kv4.2W362F/Kv1.4 Ϫ/Ϫ animals ( Figure  4 ), 19 which may reflect secondary effects due to loss of atrial I to,f and ventricular I to,f and I to,s or, alternatively, direct effects on AV nodal cells. In addition, the finding that AV block is only prominent in the Kv4.2W362F/Kv1.4 Ϫ/Ϫ animals suggests that electrical remodeling may also occur in the conducting system. In this model, the upregulation of I to,s in AV nodal cells is protective, and only when both I to,f and I to,s are eliminated is conduction measurably affected.
Molecular Dissection of Delayed Rectifier K

؉
Currents, I K,slow , in Mouse
A role for Kv1 ␣ subunits in the generation of I K,slow 23 was revealed in studies on ventricular myocytes isolated from transgenic mice expressing a truncated Kv1.1 ␣ subunit, Kv1.1N206Tag, which functions as a dominant negative. 15 Unexpectedly, I K,slow is also affected in transgenic mice expressing a truncated Kv2.1 ␣ subunit, Kv2.1N216 (Table  4) . 22, 46 Pharmacological experiments revealed that the TEA sensitivity of I K,slow is selectively eliminated in Kv2.1N216-expressing cells, whereas the sensitivity of I K,slow to micromolar 4-AP 15, 22, 47, 48 is unaffected. 24 The simplest interpretation of these combined observations is that there are two molecularly distinct components of mouse I K,slow , one (the mol/L 4-AP-sensitive) encoded by Kv1 ␣ subunits and the other ϩ channels. Kv, Kir, and two-pore ␣ subunits (A) are integral membrane proteins with six, two, or four, respectively, membrane spanning domains that assemble as tetramers or dimers to form K ϩ selective pores (B). Accessory subunits also contribute to the formation of functional cardiac K ϩ channels (C). (the TEA-sensitive) by Kv2 ␣ subunits. 24 Support for this hypothesis was provided with the demonstration that the mol/L-AP-sensitive component of I K,slow is eliminated (Table 4) in ventricular myocytes isolated from (SWAP) mice in which the Kv1.5 gene has been replaced by Kv1.1. 16 The attenuation of I K,slow in the Kv1.1N260Tag and the Kv2.1N216 transgenics is accompanied by action potential and QT prolongation (Table 4) . 15, 24 In addition, ECG recordings from Kv1.1N260Tag animals revealed an increase in the frequency of premature ventricular beats and ventricular arrhythmias, 15, 26, 49, 50 whereas spontaneous arrhythmias are not seen in Kv2.1N216 or SWAP mice. 16, 22 In Vivo Manipulation of Voltage-Gated LQT K ؉ Channel Genes Three K ϩ channel subunit genes, KCNQ1, KCNH2, and KCNE1, have been identified as loci of mutations underlying inherited Long QT (LQT) syndromes, LQT1, LQT2 and LQT5, 51 all of which are characterized by QT prolongation and abnormal T wave morphology in surface ECGs (Figure 4). KCNQ1 encodes KvLQT1 (Table 1) , which underlies the slow component of delayed rectification, I Ks , in human heart ( Figure 1 ) whereas KCNH2 encodes ERG1 (Table 1) , which underlies the rapid component of human I K , I Kr ( Figure 1 ). 51 KCNE1, in contrast, encodes the accessory subunit, minK (Table 3) , that coassembles with KvLQT1. 52, 53 Additional minK-related peptides (MiRPs) have been identified (Table  3) , and one of these, MiRP1, was suggested to combine with ERG1 to generate cardiac I Kr channels. 54 More recent studies, however, suggest that MiRP1 interacts with pore-forming subunits in addition to ERG1. [55] [56] [57] In adult mouse heart, KCNQ1 message expression is high, 58, 59 whereas KCNE1 message expression is low, 60 and electrophysiological studies have failed to detect I Ks in adult ventricular cells. 23, 32, 34, 61 Similarly, KCNH2 protein expression is high in adult mouse ventricles, 62 although I Kr density is low. 32, 34 Although these observations suggest that I Kr and I Ks are not prominent repolarizing currents in the adult mouse heart, the finding of high KCNQ1 and KCNH2 expression raises the interesting possibility that KvLQT1 and/or ERG1 encode K ϩ currents distinct from I Kr and I Ks and/or subserve functional roles other than the formation of K ϩ channels in mouse.
Mice with targeted deletions in KCNE1 (KCNE1 Ϫ/Ϫ ) and KCNQ1 (KCNQ1 Ϫ/Ϫ ) have been generated. 37,39 -41 In one KCNE1 Ϫ/Ϫ model, the entire KCNE1 coding sequence was deleted 37 whereas in the other, KCNE1 was replaced by LacZ. 39 Two KCNQ1 Ϫ/Ϫ mouse models have also been generated, in which exon 1 40 or exon 2 41 of KCNQ1 was deleted. The most striking phenotype of the KCNE1 Ϫ/Ϫ and the KCNQ1 Ϫ/Ϫ mice is a shaker/Waltzer behavior (Table 4 ) attributed to a lack of transepithelial K ϩ secretion in the inner ear and the collapse of the spaces normally containing the K ϩ -rich endolymph. 37 The deafness and inner ear defects in these animals are reminiscent of the sensorineural deficits observed in patients with Jervell and Lange-Nielsen syndrome. 63 The KCNQ1 Ϫ/Ϫ mice also exhibit gastric hyperplasia and hypochloridic gastric fluid, 40 anomalies not previously noted in LQT patients.
The two KCNE1 Ϫ/Ϫ mice express distinct cardiac phenotypes (Table 4 ). In the mice generated by Vetter and colleagues, 37 for example, the baseline ECG is normal. 58 Under bradycardic conditions, however, QT intervals are longer in KCNE1 Ϫ/Ϫ than in wild-type mice, whereas at fast heart rates, QT intervals are shorter. 58 These mice, therefore, display an accentuated QT adaptation to heart rate, as is observed in LQT1 patients. 64 Paradoxically, endocardial action potentials show a normal adaptation to rate. 65 In the LacZ-KCNE1 Ϫ/Ϫ mice, 39 in contrast, both the baseline ECG and the QT adaptation to rate are normal (Table 4) . Phenotypic differences were also seen in the KCNQ1 Ϫ/Ϫ animals. 40, 41 In the exon1-KCNQ1 Ϫ/Ϫ mice, 40 for example, heart rate, heart rate variability, ventricular repolarization, and AV conduction are normal. In contrast, prolonged QT intervals, abnormal P and T wave morphologies, and delayed AV conduction are seen in exon 2-KCNQ1 Ϫ/Ϫ animals. 41 Unexpectedly, QT intervals, as well as endocardial and epicardial monophasic action potentials recorded in isolated, perfused exon 2-KCNQ1 Ϫ/Ϫ hearts are indistinguishable from those in wild-type hearts. 41 Transgenic mice expressing a splice variant of KCNQ1 (isoform 2), which is expressed in the human heart and functions as a dominant negative, 66 have also been described. 35 The phenotype of the KCNQ1-isoform 2 mice is quite dramatic including sinus bradycardia, QT prolongation (Figure 4 ), abnormal P wave morphology, and intranodal conduction block (Table 4) . 35 Recordings from KCNQ1-isoform 2-expressing ventricular myocytes revealed that action potentials are prolonged, and that outward (I to ) and inward (I K1 ) K ϩ current densities are reduced. 35 Interestingly, the severity of the cardiac phenotype observed in the KCNQ1-isoform 2 transgenics, as well as the magnitude of the reductions in current densities, is directly correlated with the amount of the transgenic protein produced, ie, the higher the protein expression, the more severe the phenotype. 35 The line with the lowest expression is phenotypically similar to the exon 2-KCNQ1 Ϫ/Ϫ mice. 41 In vitro studies revealed that KCNQ1-isoform 2 functions as a subfamily specific dominant negative. 66 Nevertheless, it is possible that there are nonspecific effects of overexpression of the truncated protein in vivo. Although the marked reductions in I to and I K1 are reminiscent of changes seen in cardiac hypertrophy and failure, 3 there is no histological or functional evidence of cardiac hypertrophy or compromised cardiac functioning evident in KCNQ1-isoform 2 mice. 35 Transgenic mice expressing a dominant-negative long QT KCNH2 mutation have also been described. 32 ECG recordings from these animals were indistinguishable from wildtype control animals, as were the properties of ventricular action potentials (Table 4) . Although these observations are consistent with the suggestion that I Kr is not an important repolarizing K ϩ current in adult mouse heart, 61 QT intervals are prolonged in heterozygous ERG1
ϩ/Ϫ animals. 38 Homozygous ERG1
Ϫ/Ϫ mice, however, die early in fetal development In contrast to the voltage-gated K ϩ channels, the conductance of inward rectifying K ϩ channels is highest near the equilibrium potential for K ϩ , suggesting that these channels function primarily during diastole (Figure 1 ) to reduce automaticity. The inward rectifiers are generated by a large and diverse subfamily of K ϩ channel (Kir) ␣ subunit genes (Table 2 ) encoding proteins with two transmembrane domains ( Figure  2A ) that assemble as tetramers to form K ϩ selective pores ( Figure 2B) .
Based on the properties of the currents produced in heterologous expression systems, Kir2 ␣ subunits have been suggested to encode cardiac I K1 channels and, recently, mice with a targeted deletion of the coding region of Kir2.1 (Kir2.1 Ϫ/Ϫ ) were described. 42 These mice have a cleft palate and die shortly after birth, probably due to respiratory complications and the inability to suckle. Although the premature death of the Kir2.1 Ϫ/Ϫ animals has precluded characterization of adult animals, recordings from isolated newborn Kir2.1 Ϫ/Ϫ ventricular myocytes revealed that I K1 is absent (Table 4) . 28 Interestingly, a small, slowly activating inward rectifier current, distinct from I K1 , is evident in Kir2.1 Ϫ/Ϫ myocytes, although it is unclear if this current is expressed in wild-type cells. 28 Newborn Kir2.1 Ϫ/Ϫ ventricular myocytes fire action potentials spontaneously and contract to a greater extent than wild-type cells. In the intact animal, however, the expected functional consequences of this cellular phenotype are not evident. Indeed, despite the loss of I K1 , the only abnormality seen in ECG recordings from neonatal Kir2.1 Ϫ/Ϫ animals is pronounced bradycardia ( Table 4 ). The phenotype of Kir2.1 Ϫ/Ϫ mice provides an interesting comparison to individuals with Andersen's syndrome, recently shown to arise from loss of function mutations in Kir2.1 that reduce I K1 . 68 Individuals bearing Andersen's syndrome mutations can display QT prolongation, skeletal and craniofacial abnormalities, and periodic paralysis, alone or in combination. 68, 69 Similar to other LQT syndromes, some carriers display little or no phenotype. 68 These effects are likely correlates of the slowing of ventricular repolarization and the cleft palate seen in the Kir2.1 Ϫ/Ϫ mice. As in the mouse, however, the most striking feature of Andersen's syndrome may be the mildness of the cardiac phenotype in spite of the fact that the Kir 2.1 mutations likely suppress I K1 markedly.
Other members of the Kir2 subfamily are also expressed in the heart 70 and, interestingly, deletion of the open reading frame of Kir2.2 results in a quantitative reduction in I K1 . 28 Although this finding suggests that Kir2.2 also contributes to I K1 , the absence of I K1 in Kir2.1 Ϫ/Ϫ cells suggests that Kir2.2 does not give rise to functional channels in the absence of Kir2.1. 28 Biochemical studies aimed at determining if Kir2.x subunits 70 coassemble in the (mouse) heart will clearly be of interest.
Based on studies in heterologous systems, the AChregulated current, I KACh , was predicted to arise from heteromeric assembly of Kir3.1 and Kir3.4. 71 Channels encoded by these subunits are modulated by activation of muscarinic and purinergic receptors through the action of trimeric G-proteins and the binding of G-protein ␤␥ subunits. [72] [73] [74] In mice with a targeted deletion of the Kir3.4 gene (Kir3.4 Ϫ/Ϫ ), the essential role of this subunit in the generation of atrial I KACh was confirmed. 17 Although the Kir3.4
Ϫ/Ϫ animals are overtly normal, recordings from Kir3.4 Ϫ/Ϫ atrial myocytes revealed the absence of the GTP␥S-activated (I KACh ) channels ( Table 4) that are prominent in wild-type atrial cells. Interestingly, the Kir3.1 protein is made in Kir3.4
Ϫ/Ϫ cells, although it is not trafficked to the cell surface or appropriately glycosylated in the absence of Kir3.4. 75 Resting heart rates in Kir3.4 Ϫ/Ϫ and wild-type animals are not significantly different, 17 suggesting that steady-state activation of I KACh channels is not required for establishing resting heart rate in the mouse. Heart rate variability in response to stimulation of the vagus or A1 receptors, however, is reduced in Kir3.4
Ϫ/Ϫ hearts (Table 4) . 17 Approximately half of the bradycardic response to vagal stimulation is suppressed in Kir3.4 Ϫ/Ϫ animals, and the remaining response appears with a longer latency, revealing a role for I KACh in the early stage of vagal modulation. 17 In addition, atrial fibrillation does not arise in Kir3.4
Ϫ/Ϫ animals challenged with carbachol, 76 confirming that I KACh activation is a critical step in the cholinergic induction of atrial fibrillation.
Molecular Analysis and Manipulation of
Cardiac I KATP Channels ATP inhibited (I KATP ) channels 77 are expressed in many cells and have been implicated in the regulation of insulin secretion in pancreatic ␤-cells 78 and in the vasodilation observed in response to K ϩ channel openers. 79 In the heart, I KATP channels are thought to be involved in in myocardial ischemia and preconditioning. 80 I KATP channels are essentially voltageindependent and, when open, function to stabilize resting potentials and shorten action potentials (Figure 1) . 81 In heterologous systems, I KATP channels are reconstituted by coexpression of Kir6.x subunits with ATP-binding cassette proteins that encode sulfonylurea receptors, SURx. 82 Coexpression of SUR1 and Kir6.2 generates channels similar to pancreatic ␤-cell I KATP channels, and a clear genetic link was established by the demonstration that loss of function SUR1 and Kir6.2 mutations abolish I KATP in ␤-cells and cause persistent hypoglycemic hyperinsulinemia of infancy, 83, 84 whereas gain of function mutations in Kir6.2 cause hypoinsulinemic diabetes. 85 Although mRNA expression and pharmacological data suggested that cardiac sarcolemmal I KATP channels are likely encoded by Kir6.2 and SUR2A, Kir6.1 is also expressed in heart, 86 and antisense oligodeoxynucleotides against SUR1 reduce I KATP in ventricular myocytes. 25 An essential role for Kir6.2 was demonstrated with the finding that cardiac I KATP channel activity is absent in Kir6.2 Ϫ/Ϫ animals. 43, 88 Although no cardiac effects of deleting SUR1 87 have been reported, I KATP channel density is reduced (Table 4) 
in SUR2
Ϫ/Ϫ animals and the properties of the residual channels are similar to those seen on coexpression of Kir6.2 and SUR1. 27 It is possible that the targeting construct used 27 permits expression of (truncated) SUR2 and that this underlies the aberrant channel activity in SUR2
Ϫ/Ϫ cells. Alternatively, because Kir6.2 subunits can traffic alone to the cell surface, albeit inefficiently, 89 the residual I KATP channel activity in SUR2
Ϫ/Ϫ cells might reflect homomeric Kir6.2 channels. 25 Although the S-T segment of the ECG is poorly resolved in mouse (Figure 3) , there is a region following the QRS complex that is typically triangular with respect to the baseline. During ischemia, this segment can show elevation reminiscent of the ST elevation seen in larger animals and presumed to result from dispersion of ventricular repolarization. In Kir6.2 Ϫ/Ϫ animals, ST elevation is absent, 88 supporting the hypothesis that it results from variable I KATP activation and consequent heterogeneities in ventricular repolarization. Although action potentials in Kir6.2 Ϫ/Ϫ myocytes appear normal, 43 action potential shortening during ischemia or metabolic blockade is abolished (Table 4 ). These observations are consistent with previous voltage-clamp studies, 90 demonstrating that twitch shortening is maintained in metabolic blockade longer than when I KATP channels are activated. Action potential shortening and the consequent protection from Ca 2ϩ loading have been proposed to underlie a cardioprotective effect of I KATP channels. 80 Consistent with this hypothesis, recovery of Langendorff-perfused hearts from 20 minutes of global ischemia is reduced from Ϸ50% to Ϸ10% in Kir6.2 Ϫ/Ϫ animals (H. Nakaya, MD, oral communication, June 2001).
Although inhibited under normal physiological conditions, I KATP channels are expressed at much higher density than other sarcolemmal K ϩ channels. 80, 91, 92 Given the high channel density, action potentials are expected to shorten by Ϸ50% if I KATP channels are activated to only Ϸ1% of the maximal conductance. [92] [93] [94] [95] [96] Surprisingly, however, action potential durations are largely unaffected in transgenic animals expressing mutant I KATP channels with reduced ATP sensitivity. 36 In spite of a Ϸ40-fold reduction in ATP sensitivity, the mutant channels remain inactive, suggesting that additional inhibitory mechanisms may regulate cardiac I KATP channel activity in vivo.
The availability of mice with altered cardiac I KATP channel function has also enabled in situ studies focused on exploring the roles of these channels in ischemic preconditioning, in which a brief period of ischemia protects the heart from subsequent prolonged ischemia. Pharmacological studies suggest a role for I KATP channels, [97] [98] [99] although the consensus has been that preconditioning results from activation of mitochondrial, 100 not sarcolemmal, I KATP channels. [101] [102] [103] [104] In Langendorff perfused Kir 6.2 Ϫ/Ϫ hearts, however, the protective effect of preconditioning is abolished in spite of the fact that the infarction resulting from ( The application of transgenic and targeted deletion strategies in mouse has led to the identification of the ␣ subunits contributing to the formation of most of the K ϩ channels expressed in cardiac cells (Tables 1 and 2 ). Exploiting dominant negative strategies in transgenic animals, for example, has revealed that distinct Kv subfamilies encode I to,f (Kv4) 13 and I K,slow (Kv1 and Kv2) 15, 22 and has led to the identification of two molecularly-distinct (ie, Kv1-and Kv2-encoded) components of I K,slow 15,22 that could not be distinguished unequivocally using conventional electrophysiological approaches. 23 The targeted deletion of individual ␣ subunits, however, has revealed the essential subunits required for I to,f (Kv4.2), 20 I to,s (Kv1.4), 18 the mol/L 4-APsensitive I K,slow (Kv1.5), 16 I K1 (Kir2.1), 28 I KACh (Kir3.4), 17 and I KATP (Kir6.2) 14, 43 (Table 4 ). The manipulation of K ϩ channel ␣ subunit expression in mice, therefore, has identified the molecular correlates of most cardiac K ϩ channels (Tables 1  and 2 ), in spite of the marked differences in heart rates, action potential, and ECG waveforms in mice and larger mammals (Figures 1 and 3 ) that limit the usefulness of the mouse as an electrophysiological model of (human) cardiac functioning.
The in vivo molecular genetic analysis of cardiac K ϩ channels has also provided insights into the functional roles of these channels in (mouse) myocardium (Table 4) . The results obtained with the Kv4.2W362F and Kv4.2 Ϫ/Ϫ animals, for example, reveal a prominent role for I to,f in action potential repolarization in mouse atrial and ventricular myocytes. 13, 18, 19, 24 This contrasts markedly with large mammals, in which I to,f contributes primarily to early, phase 1 repolarization (Figure 1) . Interestingly, the extent of action potential and QT prolongation in animals lacking I to,f 13,19,20 is greater than when either component of I K,slow is eliminated. 15, 22 Nevertheless, action potential repolarization remains fast in animals lacking I to,f , 13, 19, 20 as well as in animals in which both I to,f and I to,s are eliminated. 19 These observations implicate an important role for the noninactivating K ϩ current, I ss , in mouse. Clearly, it will be of interest to determine the molecular identity of I ss and to explore the functional consequences of manipulating I ss in vivo.
The lack of pronounced electrophysiological effects of deletion of either KCNE1 37, 39 or KCNQ1 40,41 is consistent with previous suggestions 24, 61 that, in contrast to large mammals, I Ks does not play a major role in repolarization in the adult mouse (Figure 1 ). In contrast, there are marked phenotypic consequences of the cardiac-specific expression of a truncated KCNQ1 (isoform 2) transgene, 35 including QT prolongation and sinus bradycardia (Table 4) . Unexpectedly, recordings from KCNQ1-isoform 2-expressing ventricular cells revealed marked reductions in I to,f and I K1 . 35 Although it is unclear why these currents are affected, the attenuation of I to,f (and I K1 ?) likely underlies the QT prolongation observed in KCNQ1-isoform 2-expressing mice. 35 Interestingly, the attenuation of I Kr in KCNH2G628S-expressing ventricular cells has no measurable effects on QT intervals, revealing that, in contrast to large animals, I Kr is also not a prominent repolarizing K ϩ current in the adult mouse 32 ( Figure 1 ). The observations that I to,s is unaffected in septum cells from SWAP mice (lacking Kv1.5) 16 and that I K,slow is unaffected in Kv1.4 Ϫ/Ϫ septum cells 18 reveal that Kv1.4 and Kv1.5 encode distinct populations of voltage-gated cardiac K ϩ channels, I to,s and I K,slow (I Kur ) ( Table 1 ), and that the Kv1.4 and Kv1.5 proteins do not coassemble in the (mouse) myocardium. 16 In contrast, recent biochemical studies reveal that Kv4.2 and Kv4.3 are associated in vivo (W. Guo, MD, PhD, and J.M. Nerbonne, PhD, oral communication, August 2001) and that functional mouse ventricular I to,f channels are heteromeric. 34 In contrast, Kv4.2 homomultimers reportedly encode I to,f channels in adult rat atrial myocytes. 105 Although it seems reasonable to speculate that Kv4 ␣ subunits also underlie I to,f in other animals, Kv4.2 appears not to be expressed in non-rodent species, 106 suggesting that functional I to,f channels reflect the homomeric assembly of Kv4.3 ␣ subunits. Consistent with this hypothesis, I to,f densities are reduced in human atrial myocytes exposed to antisense oligodeoxynucleotides targeted against Kv4.3. 21 Interestingly, it has also been suggested that coassembly of Kv4.3 with the Kv channel accessory subunit, KChiP2, contributes the generation of functional I to,f channels and underlies the regional heterogeneity in I to,f expression in canine and human heart. 107 Very little is presently known, however, about the roles of KChiP2 and/or of accessory Kv ␤ subunits (Table 3) in the generation and/or the functioning of myocardial K ϩ channels. Exploring the roles of these proteins, as well as of the family of two pore K ϩ channel ␣ subunits (Table 2) , will likely be important areas of future research, and it seems certain that the mouse will also be the model of choice for these studies.
Electrophysiological Consequences of Altered K
؉
Channel Expression In Vivo
In several of the K ϩ channel mouse models (Table 4) , QT prolongation is evident, 13, 15, 19, 22, 26, 35, 41, 67 consistent with the attenuation of repolarizing K ϩ currents. In other models, however, QT prolongation is not seen, 18, 32, 42 in spite of measured changes in K ϩ current densities and action potential durations. Although the reasons for these apparent discrepancies have not been determined, some of the differences likely reflect the experimental conditions. Voltage-and current-clamp recordings, for example, are often obtained at room (rather than at physiological) temperature and at low stimulation frequencies (typically 1 Hz), ie, experimental conditions that are quite distinct from those in the mouse heart in situ. Consistent with this hypothesis, marked differences in K ϩ current and action potential waveforms are evident at physiological temperatures and stimulation frequencies. 16, 19, 48 For direct comparison of in vivo and in vitro data, therefore, it is imperative that similar experimental conditions be used.
Rather dramatic cardiac phenotypes have been seen in some of the K ϩ channel mouse models (Table 4) . Spontaneous ventricular arrhythmias, for example, are recorded in Kv1.1N206-expressing transgenics, 15, 26 which lack the mol/L 4-AP-sensitive component of I K,slow , although the reductions in outward K ϩ currents and the action potential prolongation in these animals are less than in Kv4.2W362F mice. 13, 19, 26 These observations suggest that factors in addition to prolonged repolarization play important roles in determining the propensity to develop and to sustain arrhythmias. Consistent with this hypothesis, spontaneous ventricular arrhythmias are not evident in mice expressing both the Kv4.2W362F and Kv1.1N216 dominant negative constructs, although ventricular action potential durations and QT intervals are prolonged more in these (crossed) animals than in animals expressing either dominant negative construct alone (Table 4) . 26 The simplest interpretation of these findings is that the spontaneous ventricular arrhythmias seen in the Kv1.1N206 mice reflect more than the increased action potential durations resulting from attenuation of I K,slow . Interestingly, sinus bradycardia is also evident in telemetric ECG recordings from Kv2.1 Ϫ/Ϫ 28 and KCNQ1-isoform 2-expressing 35 animals. In addition, AV block is observed in Kv4.2W362F/Kv1.4
Ϫ/Ϫ animals ( Figure 4 ), which lack I to,f and I to,s . 24 Taken together, these results suggest that there are differences in the electrical properties of cells in the conducting system of the mouse myocardium. Consistent with this hypothesis, it was recently reported that action potential waveforms in mouse His Purkinje fibers are markedly different than in ventricular cells. 108 It will clearly be of considerable interest to explore the functional consequences of altered K ϩ channel expression in Purkinje and other cells of the conducting system in genetically engineered animals.
Cardiac Remodeling in Mice With Altered K
؉
Channel Subunit Expression
In several of the mouse models described, remodeling of cardiac K ϩ currents is evident (Table 4 ). In Kv4.2W362F and Kv4.2 Ϫ/Ϫ animals, for example, I to,s is upregulated in (right and left) ventricular myocytes that do not normally express this current. 18, 20 In septum cells, which normally express I to,s , in contrast, I to,s density is unaffected by the elimination of I to,f . 18 In addition, the upregulation of I to,s is specific; the densities of I K,slow and I ss in Kv4.2W362F and Kv4.2 Ϫ/Ϫ cells are indistinguishable from those in wild-type cells. 18 -20 In addition, no changes in I K,slow and/or I ss densities are evident in Kv4.2W362FϫKv1.4 Ϫ/Ϫ cells, which lack both I to,f and I to,s . 19 Remodeling is also seen in Kv2.1N206 and SWAP ventricular cells, in which one component of I K,slow is selectively attenuated. 16, 24 In both the Kv2.1N206 and SWAP cells, the density of the component of I K,slow remaining is increased, whereas I to,f and I ss are unaffected. 16, 24 Although the results obtained in the Kv4.2W362F, 13, 19 Kv4.2 Ϫ/Ϫ , 20 SWAP, 16 and Kv2.1N206 24 suggest rather remarkable specificity in K ϩ current remodeling, there are other cases in which multiple current systems appear to be affected by the (over)expression of dominant negative K ϩ channel ␣ subunits. 33, 35 In Kv4.2N and in KCNQ1-isoform 2 ventricular cells, for example, I to,f and I K1 are attenuated. 33, 35 It is presently unclear, however, whether these changes reflect cardiac remodeling similar to that seen in the Kv4.2W362F, 13, 19 Kv4.2 Ϫ/Ϫ , 20 SWAP, 16 and Kv2.1N206 24 animals or if the unexpected effects on I to,f and I K1 simply reflect protein overexpression. Clearly, it would be of interest to be able to control the level, as well perhaps as the timing, of transgene expression. Given the progress made in developing inducible promoters, 109 -111 it seems likely that these will be exploited increasingly, and that this will facilitate studies focused on exploring the molecular mechanisms underlying cardiac remodeling in some detail.
Pathophysiological Consequences of Altered K
؉
Channel Functioning
In contrast to the marked electrophysiological consequences of the expression of mutant K ϩ channel ␣ subunits or the deletion or specific K ϩ channel subunit genes (Table 4) , in most cases, there appear not to be any detectable cardiac (or other) effects. 13,15,16,18,19,23,24,26,28,35,37,39 -41,44 Heart weights and body weights, for example, appear to be well within normal ranges and, like the animals themselves, the hearts of Kv1.1N206Tag-, Kv4.2W362F-, Kv2.1N216-, Kv4.2W362F-ϫKv1.1N206Tag-, KCNQ1-isoform 2-, or Kv4.2W362FϫKv1.4
Ϫ/Ϫ -expressing transgenics are normal. 13, 15, 19, 23, 24, 26, 35 28 In addition, although the deletion of ERG1 38 or Kir2.1 42 has profound functional consequences, the observed lethality does not reflect compromised cardiac function. Taken together, therefore, the results obtained with the vast majority of the models reveal that it is possible to markedly alter K ϩ channel expression, action potential waveforms, and ECG patterns without measurably affecting the overall physiology, behavior, or survival of the animal. In other systems, agedependent, as well as gender-dependent, effects of transgene expression have been documented. 112, 113 Clearly, experiments aimed at examining the impact of gender and aging on the phenotypic consequences of manipulating cardiac K ϩ channel expression are warranted.
In contrast to most of the transgenic and targeted deletion animals generated to date, the expression of the truncation mutant, Kv4.2N, has profound pathophysiological consequences (Table 4) , including congestive heart failure and sudden death. 33 The phenotype of these animals, therefore, is quite different from both the Kv4.2W362F transgenics and the Kv4.2 Ϫ/Ϫ animals (Table 4) , in which I to,f is eliminated and action potential durations and QT intervals are prolonged. 13 Although the underlying molecular mechanisms have not been determined, the pathology evident in the Kv4.2N animals cannot simply result from the attenuation of I to,f , as originally suggested. 33 Rather, it seems more likely that these effects reflect the deleterious effects of the (over)expression of the truncated Kv4.2N protein and/or the transgene insertion site. In this context, it is of interest to note that it has also been reported that GFP expression (alone) can result in dilated cardiac myopathy. 114 In contrast, no pathology is seen in transgenic mice expressing a GFP-tagged Kv1.5 ␣ subunit. 115 In addition, in the GFP-expressing transgenics, the cardiomyopathy was seen in the 2 (of 4 generated) lines with the highest protein (GFP) expression. 114 Taken together, these results suggest that the transgene expression level could play an important role in mediating the unexpected pathology seen in the Kv4.2N animals. 33 
Limitations of Existing Mouse Models and Future Directions
In some cases, phenotypic differences are evident in the K ϩ channel mouse models, in spite of the fact that the same subunit was targeted (Table 4) . It is presently unclear, however, whether some or all of these differences reflect the nature of the genetic manipulation (ie, expression of dominant-negative transgenes versus targeted deletion or replacement), strain-dependent (ie, C57BL6, FVB or 129Sv) effects, complex and variable cardiac remodeling, and/or secondary effects due to the elimination of K ϩ channels in the heart or in the other tissues. Given that the ␣-MHC promoter is quite robust, 30, 31 some of the differences between transgenic models or between transgenic and targeted deletion animals seem likely to reflect transgene overexpression. Clear support for this hypothesis is provided with the KCNQ1-isoform 2-expressing transgenics, 35 in which the severity of the cardiac phenotype was correlated with the amount of the mutant protein produced. It seems reasonable to suggest that in the future, transgenic animals should be generated using inducible (and cardiac specific) promoters to allow transgene expression levels to be tightly controlled. 109, 110 There are also limitations with the use of targeted deletion strategies, as is evident in the results obtained with the ERG1 Ϫ/Ϫ and the Kir2.1 Ϫ/Ϫ mice. 38, 42 These deletions are lethal either during fetal (ERG1 Ϫ/Ϫ ) or early during postnatal (Kir2.1 Ϫ/Ϫ ) development (Table 4) precluding functional studies of the roles of the channels encoded by these subunits in the adult (or developing) heart. These observations suggest that alternative experimental strategies, such as the use of methods to permit the cardiac-specific deletion of these genes, 111, 116 will be necessary to explore directly the functional roles of I K1 and I Kr , as well as of other cardiac K ϩ channels.
The combined application of inducible promoters and cardiac-specific gene ablation holds particular promise for functional studies, assuming that spatial and temporal control of gene expression is realized. These advanced methods will also enable future studies aimed at exploring the molecular mechanisms underlying cardiac remodeling. Although there are numerous possible (transcriptional, translational, and posttranslational) regulatory steps that could be involved in controlling the expression and the properties of functional cardiac K ϩ channels, little is known about the mechanisms that mediate changes in channel expression during remodeling, as well as in conjunction with myocardial damage or disease. Mice provide an excellent experimental system for exploring the underlying molecular mechanisms in detail.
